Table 4.
Office visits? | Pre-PPA use | Post-PPA use | P valuea | HIV laboratory tests? | Pre-PPA use | Post-PPA use | P value | ||||||||||
Overall, n (%) | <.001 |
|
<.001 | ||||||||||||||
|
Yes | 31 (27.2) | 60 (52.6) |
|
Yes | 25 (21.9) | 52 (45.6) |
|
|||||||||
|
No | 83 (72.8) | 54 (47.4) |
|
No | 89 (78.1) | 62 (54.4) |
|
|||||||||
Number of user acts, n (%) | |||||||||||||||||
|
None (n=21) | ||||||||||||||||
|
|
Yes | 7 (33.3) | 11 (52.4) | —b | Yes | 3 (14.3) | 9 (42.9) | — | ||||||||
|
|
No | 14 (66.7) | 10 (47.6) | — | No | 18 (85.7) | 12 (57.1) | — | ||||||||
|
Low-moderate (n=47) | ||||||||||||||||
|
|
Yes | 17 (36.2) | 26 (55.3) | — | Yes | 18 (38.3) | 21 (44.7) | — | ||||||||
|
|
No | 30 (63.8) | 21 (44.7) | — | No | 29 (61.7) | 26 (55.3) | — | ||||||||
|
High (n=46) | ||||||||||||||||
|
|
Yes | 7 (15.2) | 23 (50.0) | — | Yes | 4 (8.7) | 22 (47.8) | — | ||||||||
|
|
No | 39 (84.8) | 23 (50.0) | — | No | 42 (91.3) | 24 (52.2) | — | ||||||||
P valuec | .05 | .91 | — | — | .002 | .91 | — |
aP values compare HIV outcomes before and after PPA participation using the McNemar test of agreement.
bNot applicable.
cP values compare the categories of user activity against Pre-PPA Post-PPA HIV outcomes using the Fisher exact test.